A detailed history of Captrust Financial Advisors transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 11,350 shares of LXRX stock, worth $8,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,350
Previous 10,865 4.46%
Holding current value
$8,058
Previous $18,000 5.56%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.51 - $2.39 $732 - $1,159
485 Added 4.46%
11,350 $17,000
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $83 - $123
54 Added 0.5%
10,865 $18,000
Q1 2024

May 15, 2024

SELL
$1.3 - $3.58 $43,972 - $121,093
-33,825 Reduced 75.78%
10,811 $25,000
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.53 $18 - $27
18 Added 0.04%
44,636 $68,000
Q3 2023

Nov 14, 2023

SELL
$1.06 - $2.33 $1,983 - $4,359
-1,871 Reduced 4.02%
44,618 $48,000
Q1 2023

May 15, 2023

BUY
$1.99 - $2.68 $92,513 - $124,590
46,489 New
46,489 $112,000
Q2 2022

Aug 16, 2022

BUY
$1.31 - $2.69 $1 - $2
1 New
1 $0
Q1 2022

May 16, 2022

SELL
$1.95 - $3.89 $1 - $3
-1 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.81 - $6.16 $3 - $6
1 New
1 $0
Q3 2021

Nov 16, 2021

SELL
$3.38 - $5.35 $3 - $5
-1 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$3.45 - $9.09 $3 - $9
1 New
1 $0

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.